Copyright
©The Author(s) 2024.
World J Diabetes. Aug 15, 2024; 15(8): 1764-1777
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1764
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1764
Figure 1 Diabetic mice with five hypoglycaemic episodes exhibit impaired hypoglycaemic counterregulation.
A: Flow chart depicting the modeling process, with some content sourced from Scidraw; B: Fluctuations in blood glucose levels in diabetic mice following repeated insulin interventions; C: Alterations in plasma adrenaline levels; D: Changes in pancreatic noradrenaline levels. All the data are presented as the the mean ± SE. aP < 0.01 vs diabetic mice; bP < 0.01 vs diabetic mice with a single hypoglycaemic episode; PBG: Postprandial blood glucose; DM: Diabetic mice; DH1: Diabetic mice with a single hypoglycemic episode; DH1: Diabetic mice with a single hypoglycaemic episode; DH5: Diabetic mice with five hypoglycaemic episodes.
- Citation: Jin FX, Wang Y, Li MN, Li RJ, Guo JT. Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice. World J Diabetes 2024; 15(8): 1764-1777
- URL: https://www.wjgnet.com/1948-9358/full/v15/i8/1764.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i8.1764